Delivery Order SPE2DB20D2104-SPE2DB25FMUGD
- Not listed
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $1,118.75 to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector (2 pack) on July 18, 2025, with completion scheduled for July 21, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,869.19 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on August 13, 2025, with completion scheduled for August 14, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,626.12 delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with completion scheduled for June 23, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,610.07 to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector (2-pack) with a firm fixed price contract structure. The order was competitively awarded without set-aside designation and carries an ultimate completion date of July 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,553.20 to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector two-packs on August 27, 2025, with completion scheduled for August 28, 2025. This competitive award uses firm fixed pricing with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,209.24 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector packs (2-count). This competitively awarded, non-set-aside delivery order was issued on June 17, 2025, with an ultimate completion date of June 18, 2025, and operates under firm fixed pricing. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $6,040.16 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector two-packs. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, completed on July 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs (2-pack units) with a ceiling value of $1,504.70 and an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMUGDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,039.27 to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector packs (2 units) on June 27, 2025, with completion scheduled for June 30, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's comprehensive global pharmaceutical support vehicle. This delivery order reflects the company's ongoing role in supplying essential medical commodities, including specialty medications, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency and other federal healthcare customers. The SPE2DX contract demonstrates AmerisourceBergen's capability to fulfill diverse federal medical supply needs through open competition, with delivery orders ranging substantially in value.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 6/27/25 |